Montreal Cognitive Assessment (MoCA)
Original Editor - Arnold Fredrick D'Souza
Top Contributors - Arnold Fredrick D'Souza, Lucinda hampton, Kim Jackson and Sultan Eylem Demirhan
Objective[edit | edit source]
It was developed by Dr. Ziad S. Nasreddine and colleagues for quickly screening individuals for mild cognitive impairment.[1]
Intended Population[edit | edit source]
It can be used on the following populations:
- Older adults[2]
- Alzheimer's dementia[3]
- Vascular cognitive impairment[4]
- Stroke[5]
- Parkinson's disease[6]
- Progressive supranuclear palsy[7]
- Multiple system atrophy[7]
- Huntington's disease[8]
- Schizophrenia[9]
- Brain tumors
- Systemic lupus erythematosus
- Substance use disorders
- Idiopathic rapid eye movement sleep behavior disorder
- Obstructive sleep apnea
- Risk of falling
- Epilepsy
- Chronic obstructive pulmonary disease
- Human immunodeficiency virus infection
Method of Use[edit | edit source]
It is a clinician-reported measure than takes about 10 minutes to administer
Reference[edit | edit source]
Evidence[edit | edit source]
Reliability[edit | edit source]
Validity[edit | edit source]
Responsiveness[edit | edit source]
Miscellaneous[edit | edit source]
The video below demonstrates the use of the MoCA. It has hardcoded closed captions.
Links[edit | edit source]
For more information on MoCA, click here to visit the official website.
References[edit | edit source]
- ↑ Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9.
- ↑ Feeney J, Savva GM, O'Regan C, King-Kallimanis B, Cronin H, Kenny RA. Measurement Error, Reliability, and Minimum Detectable Change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among Community Living Middle-Aged and Older Adults. J Alzheimers Dis. 2016 May 31;53(3):1107-14.
- ↑ Lam B, Middleton LE, Masellis M, Stuss DT, Harry RD, Kiss A, Black SE. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing. J Am Geriatr Soc. 2013 Dec;61(12):2181-5.
- ↑ Koski L. Validity and applications of the Montreal cognitive assessment for the assessment of vascular cognitive impairment. Cerebrovasc Dis. 2013;36(1):6-18.
- ↑ Toglia J, Fitzgerald KA, O'Dell MW, Mastrogiovanni AR, Lin CD. The Mini-Mental State Examination and Montreal Cognitive Assessment in persons with mild subacute stroke: relationship to functional outcome. Arch Phys Med Rehabil. 2011 May;92(5):792-8.
- ↑ Gill DJ, Freshman A, Blender JA, Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov Disord. 2008 May 15;23(7):1043-6.
- ↑ 7.0 7.1 Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy. J Neural Transm (Vienna). 2016 Dec;123(12):1435-42.
- ↑ Bezdicek O, Majerova V, Novak M, Nikolai T, Ruzicka E, Roth J. Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington's disease. Appl Neuropsychol Adult. 2013 Jan 1;20(1):33-40.
- ↑ Yang Z, Abdul Rashid NA, Quek YF, Lam M, See YM, Maniam Y, Dauwels J, Tan BL, Lee J. Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia. Schizophr Res. 2018 Sep;199:58-63.